CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring (INFORM)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00707512
Recruitment Status : Terminated (Sponsor's decision.)
First Posted : July 1, 2008
Last Update Posted : July 20, 2015
Information provided by (Responsible Party):

No Study Results Posted on for this Study
  Recruitment Status : Terminated
  Estimated Primary Completion Date : August 2050
  Estimated Study Completion Date : August 2050